I pen this article with a humble sense of responsibility hoping to contribute to this critical national discourse of proffering actionable insights to nation building. This article is informed by ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...

The Equalizer In The Equalizer, this line resonates with the wisdom of experience — perfection is elusive. Striving for flawlessness can keep you stagnant. It's consistent, even small progress that ...